3,098
Views
6
CrossRef citations to date
0
Altmetric
Case Report

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma

, , , , , , & show all
Pages 325-329 | Received 10 Aug 2020, Accepted 16 Sep 2020, Published online: 10 Oct 2020

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.